This inventor holds 1 USPTO granted patent. Top assignee: Health Protection Agency. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Vladimir Artymovich Pasechnik: Innovator in Intracellular Infection Treatment
Introduction
Vladimir Artymovich Pasechnik is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of microbiology, particularly in the treatment of intracellular infections. His innovative approach combines phage therapy with targeted delivery mechanisms, showcasing his expertise in the intersection of microbiology and therapeutic development.
Latest Patents
Pasechnik holds a patent for a groundbreaking method titled "Treatment of intracellular infection." This invention involves an agent designed to combat intracellular microbial infections. The agent comprises a phage component, which is associated with a targeting moiety that directs it to a target cell. Once inside the target cell, the phage initiates the lysis of microorganisms residing within. Specifically, a mycobacteriophage is combined with a targeting moiety of transferrin. The patent also covers compositions comprising the agent, methods of preparing the agent, and its use in combating intracellular infections.
Career Highlights
Vladimir Pasechnik is affiliated with the Health Protection Agency, where he applies his research to real-world health challenges. His work has been instrumental in advancing the understanding and treatment of intracellular infections, contributing to public health initiatives.
Collaborations
Pasechnik has collaborated with notable colleagues, including Richard Sharp and Allen Douglas Glen Roberts. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Vladimir Artymovich Pasechnik is a pioneering inventor whose work in treating intracellular infections has the potential to transform therapeutic approaches in microbiology. His innovative patent and collaborations reflect his commitment to advancing health protection and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
